home
•
contacts
•
sitemap
•
search
About
Company Overview
Company History
Leadership Team
Board of Directors
Company Values
Careers
Products
Development Pipeline
Partnered Programmes
Marketed Products
Product Supplies
Business Development
Partnering
Contacts
Investors
Share Price Data
Press Releases
Regulatory Announcements
Financial Reports & Accounts
Financial Results
Presentations
BTG Share Dealing Facility
Email Alerts
Financial Calendar
Corporate Governance
Corporate Social Responsibility
Analyst Research
Investor Contacts
News
Press Releases
Events
Email Alerts
Media Contact
Products
Development Pipeline
Voraxaze™
Varisolve
®
OncoGel™
Angiotensin Therapeutic Vaccine
Pleneva™
BGC20-1531
Partnered Programmes
Campath
®
CB7630 (abiraterone)
Otelixizumab
CytoFab™
ABIO-0801
Juvidex™
Modafinil Combination
Acadra™
Nexvax2
ONX 0801
β-Amyloid Inhibitors
Marketed Products
Product Supplies
Products
>
Partnered Programmes
>
β-Amyloid Inhibitors
β-Amyloid Inhibitors
Product
β-Amyloid Inhibitors
Partner
Senexis
Indication
Alzheimer's disease
Phase
Lead optimisation
Description
Novel inhibitors of β-amyloid toxicity.
Return to Pipeline
© BTG International Ltd 2010 •
Legal Notice
•
Accessibility